Central nicotinic receptors: structure, function, ligands, and therapeutic potential. (Q33273397)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17295372%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

review article

1 reference

title

Central nicotinic receptors: structure, function, ligands, and therapeutic potential (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17295372%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17295372%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

M Novella Romanelli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17295372%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Luca Guandalini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17295372%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Elisabetta Martini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17295372%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Claudia Bonaccini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17295372%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Fulvio Gualtieri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17295372%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17295372%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17295372%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17295372%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17295372%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

746-767

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17295372%20AND%20SRC:MED&resulttype=core&format=json

Biological functions of keratinocyte cholinergic receptors

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

Exploring the nature of molecular recognition in nicotinic acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

Agonists at the alpha4beta2 nicotinic acetylcholine receptors: structure-activity relationships and molecular modelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

Relations between structure and nicotine-like activity: X-ray crystal structure analysis of (-)-cytisine and (-)-lobeline hydrochloride and a comparison with (-)-nicotine and other nicotine-like compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

Localization of acetylcholine receptor by 125I-labeled alpha-bungarotoxin binding at mouse motor endplates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Acetylcholine receptor: complex of homologous subunits

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Stereospecific nicotine receptors on rat brain membranes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Neuronal nicotinic receptors: molecular organization and regulations

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Allosteric mechanisms in normal and pathological nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Cholinergic receptors and neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Physiological roles of neuronal nicotinic receptor subtypes: new insights on the nicotinic modulation of neurotransmitter release, synaptic transmission and plasticity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Nicotine and nicotinic receptor involvement in neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Design of ligands for the nicotinic acetylcholine receptors: the quest for selectivity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Neuronal nicotinic receptors: from structure to pathology

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Nicotinic acetylcholine receptors: from structure to brain function

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Refined structure of the nicotinic acetylcholine receptor at 4A resolution

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Recent advances in Cys-loop receptor structure and function

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

The lymphocytic cholinergic system and its biological function

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

The cholinergic anti-inflammatory pathway

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Recent advances on autosomal dominant nocturnal frontal lobe epilepsy: "understanding the nicotinic acetylcholine receptor (nAChR)".

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Characterization of allelic variants at chromosome 15q14 in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Overview of nicotinic receptors and their roles in the central nervous system

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Nicotine-induced changes in neurotransmitter levels in brain areas associated with cognitive function

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

From ligand design to therapeutic efficacy: the challenge for nicotinic receptor research

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Potential applications of nicotinic ligands in the laboratory and clinic

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Nicotinic acetylcholine involvement in cognitive function in animals

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Nicotinic receptors in aging and dementia

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Effects of nicotinic stimulation on cognitive performance

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Neuronal nicotinic receptor and psychiatric disorders: functional and behavioral effects of nicotine

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Nicotinic receptors in the brain. Links between molecular biology and behavior.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Effects of nicotine on cognitive deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Effect of nicotine and nicotinic receptors on anxiety and depression

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Nicotinic acetylcholine receptors as targets for antidepressants.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Nicotinic cholinergic antagonists: a novel approach for the treatment of autism

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Nicotinic acetylcholine receptor agonists: a potential new class of analgesics

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Reduced antinociception in mice lacking neuronal nicotinic receptor subunits

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Advances in pharmacotherapy for tobacco dependence.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Developments in pharmacotherapy for tobacco dependence: past, present and future

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Neuronal nicotinic receptors and epilepsy, from genes to possible therapeutic compounds

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Nicotinic agonists, antagonists, and modulators from natural sources

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Cholinergic nicotinic receptors: Competitive ligands, allosteric modulators, and their potential applications

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Novel pyridyl ring C5 substituted analogues of epibatidine and 3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine (A-84543) as highly selective agents for neuronal nicotinic acetylcholine receptors containing beta2 subunits

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis and biological characterization of pyridohomotropanes. Structure-activity relationships of conformationally restricted nicotinoids

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

6'-Methylpyrido[3,4-b]norhomotropane: synthesis and outstanding potency in relation to the alpha4beta2 nicotinic receptor pharmacophore model

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis and pharmacological characterization of nicotinic acetylcholine receptor properties of (+)- and (-)-pyrido-[3,4-b]homotropanes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Conformationally restricted analogues of nicotine and anabasine.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Immobilized nicotinic receptor stationary phases: going with the flow in high-throughput screening and pharmacological studies

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Coaxing a pyridine nucleus to give up its aromaticity: synthesis and pharmacological characterization of novel conformationally restricted analogues of nicotine and anabasine.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis and alpha4beta2 nicotinic affinity of 2-pyrrolidinylmethoxyimines and prolinal oxime ethers

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Design of novel nicotinic ligands through 3D database searching

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

3-(4-Aminobutyn-1-yl)pyridines: binding at alpha 4 beta 2 nicotinic cholinergic receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis and analgesic activity of secondary amine analogues of pyridylmethylamine and positional isomeric analogues of ABT-594.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

3-(2,5-Dihydro-1H-pyrrol-2-ylmethoxy)pyridines: synthesis and analgesic activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Epibatidine analogues

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-substituted deschloroepibatidine analogues. Novel nicotinic antagonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis and evaluation of N-[11C]methylated analogues of epibatidine as tracers for positron emission tomographic studies of nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis and pharmacological characterization of bivalent ligands of epibatidine at neuronal nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Neuronal nAChR stereoselectivity to non-natural epibatidine derivatives

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis and pharmacological characterization of exo-2-(2'-chloro-5-pyridinyl)-7-(endo and exo)-aminobicyclo[2.2.1]heptanes as novel epibatidine analogues

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Norchloro-fluoro-homoepibatidine: specificity to neuronal nicotinic acetylcholine receptor subtypes in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis and nicotinic activity of epiboxidine: an isoxazole analogue of epibatidine

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis and nicotinic acetylcholine receptor binding affinities of 2- and 3-isoxazolyl-8-azabicyclo[3.2.1]octanes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis and nicotinic binding of novel phenyl derivatives of UB-165. Identifying factors associated with alpha7 selectivity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted-3'-phenyl-5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Novel nicotinic antagonist

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis and structure-activity relationships of 5-substituted pyridine analogues of 3.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis and analgesic activity of hydrochlorides and quaternary ammoniums of epibatidine incorporated with amino acid ester

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Halogenated cytisine derivatives as agonists at human neuronal nicotinic acetylcholine receptor subtypes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Halogenated and isosteric cytisine derivatives with increased affinity and functional activity at nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

3,5-Bicyclic aryl piperidines: a novel class of alpha4beta2 neuronal nicotinic receptor partial agonists for smoking cessation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Novel potent ligands for the central nicotinic acetylcholine receptor: synthesis, receptor binding, and 3D-QSAR analysis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Structure-affinity relationships of a unique nicotinic ligand: N(1)-dimethyl-N(4)-phenylpiperazinium iodide (DMPP).

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

New ligands with affinity for the alpha4beta2 subtype of nicotinic acetylcholine receptors. Synthesis, receptor binding, and 3D-QSAR modeling

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

N,N-disubstituted piperazines: synthesis and affinities at alpha4beta2(*) and alpha7(*) neuronal nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Effects at a distance in alpha 7 nAChR selective agonists: benzylidene substitutions that regulate potency and efficacy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Activity of alpha7-selective agonists at nicotinic and serotonin 5HT3 receptors expressed in Xenopus oocytes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Molecular dissection of tropisetron, an alpha7 nicotinic acetylcholine receptor-selective partial agonist

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

(+)-3-[2-(Benzo[b]thiophen-2-yl)-2-oxoethyl]-1-azabicyclo[2.2.2]octane as potent agonists for the alpha7 nicotinic acetylcholine receptor.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

(-)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis and evaluation of [125I]I-TSA as a brain nicotinic acetylcholine receptor alpha7 subtype imaging agent

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis and evaluation of phenylcarbamate derivatives as ligands for nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

2-(Arylmethyl)-3-substituted quinuclidines as selective alpha 7 nicotinic receptor ligands

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Neuronal nicotinic acetylcholine receptor binding affinities of boron-containing nicotine analogues

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

The characterization of a novel rigid nicotine analog with alpha7-selective nAChR agonist activity and modulation of agonist properties by boron inclusion

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2* and alpha7* neuronal nicotinic receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

QSAR modeling of mono- and bis-quaternary ammonium salts that act as antagonists at neuronal nicotinic acetylcholine receptors mediating dopamine release

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonist: inhibition of S(-)-nicotine-evoked [(3)H]dopamine overflow from superfused rat striatal slices

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

N-n-alkylnicotinium analogs, a novel class of antagonists at alpha 4 beta 2* nicotinic acetylcholine receptors: inhibition of S(-)-nicotine-evoked 86Rb+ efflux from rat thalamic synaptosomes.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Development of subtype-selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

bis-Azaaromatic quaternary ammonium analogues: ligands for alpha4beta2* and alpha7* subtypes of neuronal nicotinic receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Effect of a novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted phenyl)deschloroepibatidine analogues. Novel nicotinic antagonist

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

2-Fluoro-3-(4-nitro-phenyl)deschloroepibatidine is a novel potent competitive antagonist of human neuronal alpha4beta2 nAChRs

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Epibatidine analogues as selective ligands for the alpha(x)beta2-containing subtypes of nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

6-(2-Phenylethyl)nicotine: a novel nicotinic cholinergic receptor ligand

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Identification and synthesis of novel alkaloids from the root system of Nicotiana tabacum: affinity for neuronal nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Methyllycaconitine analogues have mixed antagonist effects at nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Structure-activity studies with ring E analogues of methyllycaconitine on bovine adrenal alpha3beta4* nicotinic receptors.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Pharmacological characterisation of strychnine and brucine analogues at glycine and alpha7 nicotinic acetylcholine receptors.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Blockade of nicotinic receptors of bovine adrenal chromaffin cells by nanomolar concentrations of atropine

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Toxin insights into nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

alpha-Conotoxins as selective probes for nicotinic acetylcholine receptor subclasses

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Alpha S-conotoxin RVIIIA: a structurally unique conotoxin that broadly targets nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Alpha-RgIA: a novel conotoxin that specifically and potently blocks the alpha9alpha10 nAChR.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Alpha-selenoconotoxins, a new class of potent alpha7 neuronal nicotinic receptor antagonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Engineering stable peptide toxins by means of backbone cyclization: stabilization of the alpha-conotoxin MII.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Alpha-conotoxin OmIA is a potent ligand for the acetylcholine-binding protein as well as alpha3beta2 and alpha7 nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Identification of a Novel Class of Nicotinic Receptor Antagonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

SLURP-2: A novel cholinergic signaling peptide in human mucocutaneous epithelium.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Biological effects of SLURP-1 on human keratinocytes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

beta -Amyloid peptide activates alpha 7 nicotinic acetylcholine receptors expressed in Xenopus oocytes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Beta-amyloid peptide activates non-alpha7 nicotinic acetylcholine receptors in rat basal forebrain neurons

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

beta -Amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Amyloid beta(1-42) peptide alters the gating of human and mouse alpha-bungarotoxin-sensitive nicotinic receptors.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

The inhibitory and facilitatory actions of amyloid-beta peptides on nicotinic ACh receptors and AMPA receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

beta-Amyloid directly inhibits human alpha4beta2-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Anesthetics as chemical tools to study the structure and function of nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Novel modulation of a nicotinic receptor channel mutant reveals that the open state is stabilized by ethanol

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Acetylcholine nicotinic receptors: finding the putative binding site of allosteric modulators using the "blind docking" approach

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiators.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Unexpected sensitivity of the human alpha7 neuronal nicotinic acetylcholine receptor to aminoglycosides

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis of poison-frog alkaloids 237D, 207A, and two congeners of 235B' for evaluation to inhibitory effect of nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Alkaloids indolizidine 235B', quinolizidine 1-epi-207I, and the tricyclic 205B are potent and selective noncompetitive inhibitors of nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Marine alkaloids (-)-pictamine and (-)-lepadin B block neuronal nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Anti-HIV benzylisoquinoline alkaloids and flavonoids from the leaves of Nelumbo nucifera, and structure-activity correlations with related alkaloids

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Effects of the plant alkaloid tetrandrine on human nicotinic acetylcholine receptors.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Simplified tetrandrine congeners as possible antihypertensive agents with a dual mechanism of action

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Evaluation of benzyltetrahydroisoquinolines as ligands for neuronal nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis and biological evaluation of 18-methoxycoronaridine congeners. Potential antiaddiction agents

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Synthesis of enantiomerically pure (+)- and (-)-18-methoxycoronaridine hydrochloride and their preliminary assessment as anti-addictive agents.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Effects of dextrorotatory morphinans on alpha3beta4 nicotinic acetylcholine receptors expressed in Xenopus oocytes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Targeting ischemic stroke with a novel opener of ATP-sensitive potassium channels in the brain

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Iptakalim as a human nicotinic acetylcholine receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Inhibition of human alpha 7 nicotinic acetylcholine receptors by open channel blockers of N-methyl-D-aspartate receptors.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Comments on "Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than N-methyl-D-aspartate receptors in rat hippocampal neurons".

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Musings on alpha4beta2 nicotinic acetylcholine (nACh) receptor pharmacophore models

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Structure and activity of acetylcholine

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

The ensemble approach to distance geometry: application to the nicotinic pharmacophore

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

A computational model of the nicotinic acetylcholine binding site

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Structure/activity and molecular modeling studies of the lophotoxin family of irreversible nicotinic receptor antagonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

32 Pharmacophore for nicotinic agonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Ligands of neuronal nicotinic acetylcholine receptor (nAChR): inferences from the Hansch and 3-D quantitative structure-activity relationship (QSAR) Models

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Neuronal nicotinic acetylcholine receptor agonists: pharmacophores, evolutionary QSAR and 3D-QSAR models

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

The identification of novel structural compound classes exhibiting high affinity for neuronal nicotinic acetylcholine receptors and analgesic efficacy in preclinical models of pain.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Improving the nicotinic pharmacophore with a series of (Isoxazole)methylene-1-azacyclic compounds: synthesis, structure-activity relationship, and molecular modeling

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

https://api.crossref.org/works/10.1002%2FCMDC.200600207

1 reference

7 January 2021

alpha4beta2 nACh receptor pharmacophore models

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

3D QSAR analyses-guided rational design of novel ligands for the (alpha4)2(beta2)3 nicotinic acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Molecular modeling of mono- and bis-quaternary ammonium salts as ligands at the alpha4beta2 nicotinic acetylcholine receptor subtype using nonlinear techniques

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Purification of acetylcholine receptors from Torpedo claifornica electroplax by affinity chromatography

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Progress in the purification of the cholinergic receptor protein from Electrophorus electricus by affinity chromatography

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Large-scale purification of the acetylcholine-receptor protein in its membrane-bound and detergent-extracted forms from Torpedo marmorata electric organ

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Affinity-labeling of purified acetylcholine receptor from Torpedo californica.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Photoaffinity labeling and quaternary structure of the acetylcholine receptor from Torpedo californica

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Biochemical properties of acetylcholine receptor subunits from Torpedo californica

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Ligand binding sites and subunit interactions of Torpedo californica acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Structural studies of a membrane-bound acetylcholine receptor from Torpedo californica

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Demonstration of the transmembrane nature of the acetylcholine receptor by labeling with anti-receptor antibodies

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Transmembrane topology of acetylcholine receptor subunits probed with photoreactive phospholipids

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Structural homology of Torpedo californica acetylcholine receptor subunits

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Subunit structure of the acetylcholine receptor from Electrophorus electricus

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Amino acid sequence homology between "alpha" subunits from Torpedo and Electrophorus acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Location of functional regions of acetylcholine receptor α-subunit by site-directed mutagenesis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

A structural model of the acetylcholine receptor channel based on partition energy and helix packing calculations

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

A model for the acetylcholine binding site of the nicotinic acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Topological mapping of acetylcholine receptor: evidence for a model with five transmembrane segments and a cytoplasmic COOH-terminal peptide

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

A structural and dynamic model for the nicotinic acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Tubular crystals of acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Quaternary structure of the acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Three-dimensional structure of the acetylcholine receptor by cryoelectron microscopy and helical image reconstruction

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Arrangement of the acetylcholine receptor subunits in the resting and desensitized states, determined by cryoelectron microscopy of crystallized Torpedo postsynaptic membranes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Three-dimensional structure of the nicotinic acetylcholine receptor and location of the major associated 43-kD cytoskeletal protein, determined at 22 A by low dose electron microscopy and x-ray diffraction to 12.5 A.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Complete mRNA coding sequence of the acetylcholine binding alpha-subunit of Torpedo marmorata acetylcholine receptor: a model for the transmembrane organization of the polypeptide chain

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

The noncompetitive blocker [3H]chlorpromazine labels three amino acids of the acetylcholine receptor gamma subunit: implications for the alpha-helical organization of regions MII and for the structure of the ion channel

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Nicotinic acetylcholine receptor at 9 A resolution.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Acetylcholine receptor channel imaged in the open state

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Structure and gating mechanism of the acetylcholine receptor pore

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

The secondary structure of acetylcholine receptor reconstituted in a single lipid component as determined by Raman spectroscopy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Stabilization of acetylcholine receptor secondary structure by cholesterol and negatively charged phospholipids in membranes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Secondary structure of the nicotinic acetylcholine receptor: implications for structural models of a ligand-gated ion channel.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

A model of the nicotinic receptor extracellular domain based on sequence identity and residue location

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Predicted structure of the extracellular region of ligand-gated ion-channel receptors shows SH2-like and SH3-like domains forming the ligand-binding site

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

A glia-derived acetylcholine-binding protein that modulates synaptic transmission.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Atomic Structure of Acetylcholinesterase from Torpedo californica : A Prototypic Acetylcholine-Binding Protein

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

From ab initio quantum mechanics to molecular neurobiology: a cation-pi binding site in the nicotinic receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Molecular recognition in nicotinic acetylcholine receptors: the importance of pi-cation interactions

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Lysine scanning mutagenesis delineates structural model of the nicotinic receptor ligand binding domain

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Models of the extracellular domain of the nicotinic receptors and of agonist- and Ca2+-binding sites

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Structural model of nicotinic acetylcholine receptor isotypes bound to acetylcholine and nicotine

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

A structural model of agonist binding to the α3β4 neuronal nicotinic receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Experimentally based model of a complex between a snake toxin and the alpha 7 nicotinic receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Asymmetric structural motions of the homomeric alpha7 nicotinic receptor ligand binding domain revealed by molecular dynamics simulation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Structural and ligand recognition characteristics of an acetylcholine-binding protein from Aplysia californica

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Crystal structure of a Cbtx-AChBP complex reveals essential interactions between snake alpha-neurotoxins and nicotinic receptors.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Crystal structure of nicotinic acetylcholine receptor homolog AChBP in complex with an alpha-conotoxin PnIA variant.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Crystal structure of acetylcholine-binding protein from Bulinus truncatus reveals the conserved structural scaffold and sites of variation in nicotinic acetylcholine receptors.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Randomized placebo-controlled study of the nicotinic agonist SIB-1508Y in Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Cognitive Enhancing Properties and Tolerability of Cholinergic Agents in Mice: A Comparative Study of Nicotine, Donepezil, and SIB-1553A, a Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

TC-1734: an orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, neuroprotective and long-lasting cognitive effects.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

TC-2559 excites dopaminergic neurones in the ventral tegmental area by stimulating alpha4beta2-like nicotinic acetylcholine receptors in anaesthetised rats.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

The neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel alpha7 ligand, is prevented through angiotensin II activation of a tyrosine phosphatase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Varenicline: a review of its use as an aid to smoking cessation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetize

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Selective alpha7 nicotinic acetylcholine receptor ligands

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

Nicotinic acetylcholine receptors and imaging

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021

A novel nicotinic acetylcholine receptor antagonist radioligand for PET studies

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600207

7 January 2021